Monoclonal Antibody-Directed Cytotoxic Therapy
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 15 (1) , 1-13
- https://doi.org/10.2165/00002512-199915010-00001
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- The Biologic Effects of C225, A Chimeric Monoclonal Antibody to the EGFR, on Human Prostate CarcinomaJournal of Immunotherapy, 1996
- Anti-Renal-Cell Carcinoma Chimeric Antibody G250 Facilitates Antibody-Dependent Cellular Cytotoxicity with In Vitro and In Vivo Interleukin-2-Activated EffectorsJournal of Immunotherapy, 1996
- Clinical and Immunological Studies in Advanced Cancer Patients Sequentially Treated with Anti CD3 Monoclonal Antibody (OKT3) and Interleukin-2Leukemia & Lymphoma, 1996
- Trends in Cancer Mortality in 15 Industrialized Countries, 1969-1986JNCI Journal of the National Cancer Institute, 1992
- The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugatesInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1991
- In vitro antitumor activity of 2'-deoxy-5-fluorouridine-monoclonal antibody conjugatesBioconjugate Chemistry, 1991
- The linkage of cytotoxic drugs to monoclonal antibodies for the treatment of cancerBioconjugate Chemistry, 1990
- Therapeutic Index: A Vital Component in Selection of Anticancer Agents for Clinical TrialJNCI Journal of the National Cancer Institute, 1989
- Anti‐tumour activity of aminopterin‐monoclonal antibody conjugates; in vitro and in vivo comparison with methotrexate‐monoclonal antibody conjugatesImmunology & Cell Biology, 1987
- RESPONSE OF CUTANEOUS T CELL LYMPHOMA TO THERAPY WITH HYBRIDOMA MONOCLONAL ANTIBODYThe Lancet, 1981